My Quote Request
No products added yet
6505-01-110-3955
20 Products
NDC10223-0201-01
BENZOCAINE,BUTAMBEN,AND TETRACAINE HYDROCHLORIDE TOPICAL AEROSOL
NSN, MFG P/N
6505011103955
NSN
6505-01-110-3955
NDC10223-0201-01
BENZOCAINE,BUTAMBEN,AND TETRACAINE HYDROCHLORIDE TOPICAL AEROSOL
NSN, MFG P/N
6505011103955
NSN
6505-01-110-3955
MFG
AMERISOURCEBERGEN DRUG CORPORATION DIV CORPORATE OFFICE
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.500 PERCENTAGE, W/V BENZALKONIUM CHLORIDE ACTIVE INGREDIENT AND 14.000 PERCENTAGE, W/V BENZOCAINE ACTIVE INGREDIENT AND 2.000 PERCENTAGE, W/V BUTAMBEN ACTIVE INGREDIENT AND 2.000 PERCENTAGE, W/V TETRACAINE HYDROCHLORIDE ACTIVE INGREDIENT AND 0.005
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BENZOCAINE BUTAMBEN AND TETRACAINE HCL TOPICAL AEROSOL 56GM
PRIMARY CONTAINER CONTENT QUANTITY: 56.000 GRAMS
PRIMARY CONTAINER TYPE: BOTTLE, AEROSOL
SPECIAL FEATURES: IN ABLAND WATER SOLUABLE BASE; CONTAINS 0.50 PCT BENZALKONIUM CHLORIDE AND 0.05 PCT CETYL DIMETHYL ETHYL AMMONIUM BROMIDE AS PRESERVATIVES; WITH ONE DETACHABLE,STAINLESS STEEL CANNULA,WHICH,WHEN ATTACHED TO THE PROTRUDING PLASTIC TUBING ON THE
~1: BOTTLE,PERMITS ADMINISTRATION OF ANESTHETIC TO THE DESIRED SITE OF APPLICATION WHEN ACTIVATED
~1: PERCENTAGE W/V CETYL DIMETHYL ETHYL AMMONIUM BROMIDE ACTIVE INGREDIENT
Related Searches:
2A0114
DEXTROSE INJECTION,USP
NSN, MFG P/N
6505011103956
NSN
6505-01-110-3956
MFG
BAXTER HEALTHCARE CORP FENWAL DIV GOVERNMENT SALES LCII-03
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 70.000 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DEXTROSE INJECTION USP 70% 500ML BT 6S
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: BOTTLE WITH A RATED CAPACITY OF NOT LESS THAN 1000 ML; THE STOPPER SHALL ACCEPT AND RETAIN THE PIERCING DEVICE OF STOCKLISTED INTRAVENOUS INJECTION SETS
TOTAL PRIMARY CONTAINER QUANTITY: 6
Related Searches:
NDC00264-1129-01
DEXTROSE INJECTION,USP
NSN, MFG P/N
6505011103956
NSN
6505-01-110-3956
NDC00264-1129-01
DEXTROSE INJECTION,USP
NSN, MFG P/N
6505011103956
NSN
6505-01-110-3956
MFG
B BRAUN MEDICAL INC WOUND CARE DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 70.000 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DEXTROSE INJECTION USP 70% 500ML BT 6S
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: BOTTLE WITH A RATED CAPACITY OF NOT LESS THAN 1000 ML; THE STOPPER SHALL ACCEPT AND RETAIN THE PIERCING DEVICE OF STOCKLISTED INTRAVENOUS INJECTION SETS
TOTAL PRIMARY CONTAINER QUANTITY: 6
Related Searches:
NDC00338-0033-13
DEXTROSE INJECTION,USP
NSN, MFG P/N
6505011103956
NSN
6505-01-110-3956
NDC00338-0033-13
DEXTROSE INJECTION,USP
NSN, MFG P/N
6505011103956
NSN
6505-01-110-3956
MFG
BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 70.000 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DEXTROSE INJECTION USP 70% 500ML BT 6S
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: BOTTLE WITH A RATED CAPACITY OF NOT LESS THAN 1000 ML; THE STOPPER SHALL ACCEPT AND RETAIN THE PIERCING DEVICE OF STOCKLISTED INTRAVENOUS INJECTION SETS
TOTAL PRIMARY CONTAINER QUANTITY: 6
Related Searches:
S1290-50
DEXTROSE INJECTION,USP
NSN, MFG P/N
6505011103956
NSN
6505-01-110-3956
MFG
B BRAUN MEDICAL INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 70.000 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DEXTROSE INJECTION USP 70% 500ML BT 6S
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: BOTTLE WITH A RATED CAPACITY OF NOT LESS THAN 1000 ML; THE STOPPER SHALL ACCEPT AND RETAIN THE PIERCING DEVICE OF STOCKLISTED INTRAVENOUS INJECTION SETS
TOTAL PRIMARY CONTAINER QUANTITY: 6
Related Searches:
NDC00054-3785-63
MORPHINE SULFATE ORAL SOLUTION
NSN, MFG P/N
6505011107196
NSN
6505-01-110-7196
NDC00054-3785-63
MORPHINE SULFATE ORAL SOLUTION
NSN, MFG P/N
6505011107196
NSN
6505-01-110-7196
MFG
BOEHRINGER INGELHEIM ROXANE INC. DIV SUB OF BOEHRINGER INGELHEIM CORP
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 MILLIGRAMS MORPHINE SULFATE PER MILLILITER
III CONTROLLED SUBSTANCE CLASSIFICATION: SCHEDULE II
III PART NAME ASSIGNED BY CONTROLLING AGENCY: MORPHINE SULFATE ORAL SOLUTION 10MG/5ML 500ML BT
III PROTECTIVE STORAGE FEATURE: VAULT STORAGE
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
X1-490-352
VITAMIN A AND D OIN
NSN, MFG P/N
6505011109372
NSN
6505-01-110-9372
MFG
PUBLIC HEALTH SERVICE
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: 1 TUBE,EACH CONTAINING 2 OZ
Related Searches:
NDC51079-0587-20
THIOTHIXENE CAPSULES,USP
NSN, MFG P/N
6505011109441
NSN
6505-01-110-9441
NDC51079-0587-20
THIOTHIXENE CAPSULES,USP
NSN, MFG P/N
6505011109441
NSN
6505-01-110-9441
MFG
UDL LABORATORIES INC
Description
(NON-CORE DATA) UNIT PACKAGE TYPE: PACKAGE
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 MILLIGRAMS THIOTHIXENE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
FEATURES PROVIDED: UNIT DOSE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: THIOTHIXENE CAPSULES USP 2MG 100S PG
PRIMARY CONTAINER TYPE: STRIP
Related Searches:
18
LANOLIN,USP
NSN, MFG P/N
6505011109442
NSN
6505-01-110-9442
MFG
UNITED STATES PHARMACOPEIAL CONVENTION INC. THE DBA UNITED STATES PHARMACOPEIA
Description
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 OUNCES
PRIMARY CONTAINER TYPE: TUBE, PLASTIC SQUEEZE
TOTAL PRIMARY CONTAINER QUANTITY: 1
Related Searches:
MCKESSON CHEMICALS ALCOHOL
ALCOHOL,RUBBING,USP
NSN, MFG P/N
6505011109444
NSN
6505-01-110-9444
MCKESSON CHEMICALS ALCOHOL
ALCOHOL,RUBBING,USP
NSN, MFG P/N
6505011109444
NSN
6505-01-110-9444
MFG
GENERAL SERVICES ADMINISTRATION FEDERAL SUPPLY SERVICE
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 99.000 PERCENTAGE, W/W ISOPROPYL ALCOHOL ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 GALLONS
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC
Related Searches:
NDC00182-1919-89
CYCLOBENZAPRINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505011109926
NSN
6505-01-110-9926
NDC00182-1919-89
CYCLOBENZAPRINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505011109926
NSN
6505-01-110-9926
MFG
IVAX CORP
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS CYCLOBENZAPRINE HYDROCHLORIDE ACTIVE INGREDIENT
FEATURES PROVIDED: UNIT DOSE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CYCLOBENZAPRINE HYDROCHLORIDE TABLETS USP 10MG 100S PG
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP
PROTECTIVE STORAGE FEATURE: EXPIRATION DATED
TOTAL PRIMARY CONTAINER QUANTITY: 1
Related Searches:
NDC51079-0644-20
CYCLOBENZAPRINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505011109926
NSN
6505-01-110-9926
NDC51079-0644-20
CYCLOBENZAPRINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505011109926
NSN
6505-01-110-9926
MFG
UDL LABORATORIES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS CYCLOBENZAPRINE HYDROCHLORIDE ACTIVE INGREDIENT
FEATURES PROVIDED: UNIT DOSE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CYCLOBENZAPRINE HYDROCHLORIDE TABLETS USP 10MG 100S PG
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP
PROTECTIVE STORAGE FEATURE: EXPIRATION DATED
TOTAL PRIMARY CONTAINER QUANTITY: 1
Related Searches:
DILANTIN
PHENYTOIN ORAL SUSPENSION,USP
NSN, MFG P/N
6505011112108
NSN
6505-01-111-2108
DILANTIN
PHENYTOIN ORAL SUSPENSION,USP
NSN, MFG P/N
6505011112108
NSN
6505-01-111-2108
MFG
PARKE-DAVIS DIV OF WARNER-LAMBERT CO
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 125.000 MILLIGRAMS PHENYTOIN PER 5 MILLILITERS
FEATURES PROVIDED: UNIT DOSE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PHENYTION ORAL SUSPENSION USP 5ML POUCH 100S
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 MILLILITERS
PRIMARY CONTAINER TYPE: POUCH, FOIL LAMINATE
TOTAL PRIMARY CONTAINER QUANTITY: 100
Related Searches:
DILANTIN-125
PHENYTOIN ORAL SUSPENSION,USP
NSN, MFG P/N
6505011112108
NSN
6505-01-111-2108
DILANTIN-125
PHENYTOIN ORAL SUSPENSION,USP
NSN, MFG P/N
6505011112108
NSN
6505-01-111-2108
MFG
PARKE-DAVIS DIV OF WARNER-LAMBERT CO
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 125.000 MILLIGRAMS PHENYTOIN PER 5 MILLILITERS
FEATURES PROVIDED: UNIT DOSE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PHENYTION ORAL SUSPENSION USP 5ML POUCH 100S
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 MILLILITERS
PRIMARY CONTAINER TYPE: POUCH, FOIL LAMINATE
TOTAL PRIMARY CONTAINER QUANTITY: 100
Related Searches:
NDC00071-2214-40
PHENYTOIN ORAL SUSPENSION,USP
NSN, MFG P/N
6505011112108
NSN
6505-01-111-2108
NDC00071-2214-40
PHENYTOIN ORAL SUSPENSION,USP
NSN, MFG P/N
6505011112108
NSN
6505-01-111-2108
MFG
PARKE-DAVIS DIV OF WARNER-LAMBERT CO
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 125.000 MILLIGRAMS PHENYTOIN PER 5 MILLILITERS
FEATURES PROVIDED: UNIT DOSE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PHENYTION ORAL SUSPENSION USP 5ML POUCH 100S
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 MILLILITERS
PRIMARY CONTAINER TYPE: POUCH, FOIL LAMINATE
TOTAL PRIMARY CONTAINER QUANTITY: 100
Related Searches:
NDC00364-2434-01
AMOXAPINE TABLETS,USP
NSN, MFG P/N
6505011113194
NSN
6505-01-111-3194
NDC00364-2434-01
AMOXAPINE TABLETS,USP
NSN, MFG P/N
6505011113194
NSN
6505-01-111-3194
MFG
HENRY SCHEIN INC. DIV SPECIAL MARKETS / FEDERAL SALES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 MILLIGRAMS AMOXAPINE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: AMOXAPINE TABLETS 100MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00591-5715-01
AMOXAPINE TABLETS,USP
NSN, MFG P/N
6505011113194
NSN
6505-01-111-3194
NDC00591-5715-01
AMOXAPINE TABLETS,USP
NSN, MFG P/N
6505011113194
NSN
6505-01-111-3194
MFG
WATSON LABS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 MILLIGRAMS AMOXAPINE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: AMOXAPINE TABLETS 100MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00364-2433-01
AMOXAPINE TABLETS,USP
NSN, MFG P/N
6505011113195
NSN
6505-01-111-3195
NDC00364-2433-01
AMOXAPINE TABLETS,USP
NSN, MFG P/N
6505011113195
NSN
6505-01-111-3195
MFG
HENRY SCHEIN INC. DIV SPECIAL MARKETS / FEDERAL SALES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS AMOXAPINE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: AMOXAPINE TABLETS 50MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00591-5714-01
AMOXAPINE TABLETS,USP
NSN, MFG P/N
6505011113195
NSN
6505-01-111-3195
NDC00591-5714-01
AMOXAPINE TABLETS,USP
NSN, MFG P/N
6505011113195
NSN
6505-01-111-3195
MFG
WATSON PHARMACEUTICALS INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS AMOXAPINE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: AMOXAPINE TABLETS 50MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00364-7030-16
KAOLIN AND PECTIN SUSPENSION
NSN, MFG P/N
6505011115268
NSN
6505-01-111-5268
NDC00364-7030-16
KAOLIN AND PECTIN SUSPENSION
NSN, MFG P/N
6505011115268
NSN
6505-01-111-5268
MFG
SCHEIN HENRY INC
Description
PRIMARY CONTAINER CONTENT QUANTITY: 16.000 FLUID OUNCES
PRIMARY CONTAINER TYPE: BOTTLE
